$CCCC

$3.05▲ +0.7% YTD

7 SEC 13D/G filings tracked · Last updated Sep 25, 2026

Filing History

CP $3.05▲ +0.7%Sep 25, 2026 · ThinkSabio Blog

$CCCC - C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFI…

News

CCCC ▲ +2.4% - C4 Therapeutics, Inc.

CP $3.88▲ +2.4%Sep 3, 2026 · ThinkSabio Blog

$CCCC - C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase…

SEC 13D/G

CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$4.31▲ 123.32%Aug 14, 2026 · ThinkSabio Blog

$CCCC SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CCCC C4 Therapeutics, Inc. : $4.31 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$4.31▲ 123.32%Aug 14, 2026 · ThinkSabio Blog

$CCCC SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CCCC C4 Therapeutics, Inc. : $4.31 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

CCCC - C4 Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$4.23▲ 119.17%Aug 14, 2026 · ThinkSabio Blog

$CCCC SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CCCC C4 Therapeutics, Inc. : $4.23 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

CCCC - C4 Therapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified

$3.90▲ 102.07%Aug 12, 2026 · ThinkSabio Blog

$CCCC SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CCCC C4 Therapeutics, Inc. : $3.90 Sector: Healthcare | YTD: 🔼+…

SEC 13D/G

$CCCC SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks Simplified

$3.58▲ 85.49%Jul 27, 2026 · ThinkSabio Blog

$CCCC SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CCCC : $3.58 Sector: Healthcare | YTD: 🔼+ 85.49% The SEC disclo…